NCT07742046Enrolling by invitation
Feasibility of Non-invasive Hemodynamic Assessment by 5D Flow in Congenital Heart Disease
Evaluation of the Feasibility of Non-invasive Hemodynamic Assessment by 5D Flow in Congenital Heart Disease in Comparison to Right-left Heart Catheterization
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
This study evaluates whether new flow parameters of the cardiac magnetic resonance imaging (MRI) allow evaluation of parameters for which usually invasive rigth-left heart catheterization are necessary. Patients who require a right-left heart catheterization will undergo the same day a heart catheterization in the MRI. Parameters obtained by MRI will be compared to the gold-standard, the right-left heart catheterization.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 130 (estimated)
- First submitted
- 7 Jul 2026
- Start date
- 6 Jul 2026
- Primary completion date
- 31 May 2029
- Lead sponsor
- Tobias Rutz
- NCT number
- NCT07742046
What you commit to
- Study type: Interventional
- Planned participants: 130
- From 6 Jul 2026 to the primary completion date, 31 May 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Participants unable to comply with study procedures due to language barriers, cognitive or psychological limitations, or lack of legal consent.
- Patients with contraindications to RL-HC or CMR.
- Patients not having a clinical indication to RL-HC.
Who the study is looking for
- Referral for work-up of known or suspected pulmonary hypertension (PH), RVOT pathology, or Fontan-type repair with a clinical indication for RL-HC.
- Ability to provide informed consent or have consent provided by a legal representative (and assent for minors aged 16-18).
- Male or female participants of all ethnicities and sociodemographic backgrounds
Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Lausanne University Hospital Coordinator of this site? Confirm its status | Lausanne | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.